NasdaqGS - Delayed Quote USD

Intuitive Surgical, Inc. (ISRG)

377.08 +8.15 (+2.21%)
At close: April 23 at 4:00 PM EDT
377.00 -0.08 (-0.02%)
After hours: April 23 at 7:59 PM EDT
Loading Chart for ISRG
DELL
  • Previous Close 368.93
  • Open 370.37
  • Bid 376.48 x 100
  • Ask 377.12 x 100
  • Day's Range 368.68 - 379.77
  • 52 Week Range 254.85 - 403.76
  • Volume 1,836,586
  • Avg. Volume 1,615,954
  • Market Cap (intraday) 133.753B
  • Beta (5Y Monthly) 1.38
  • PE Ratio (TTM) 68.19
  • EPS (TTM) 5.53
  • Earnings Date Jul 18, 2024 - Jul 22, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 418.24

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

www.intuitive.com

13,676

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ISRG

Performance Overview: ISRG

Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ISRG
11.77%
S&P 500
6.30%

1-Year Return

ISRG
25.60%
S&P 500
22.67%

3-Year Return

ISRG
31.59%
S&P 500
22.63%

5-Year Return

ISRG
130.37%
S&P 500
74.37%

Compare To: ISRG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ISRG

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    130.87B

  • Enterprise Value

    126.07B

  • Trailing P/E

    66.60

  • Forward P/E

    59.17

  • PEG Ratio (5yr expected)

    3.91

  • Price/Sales (ttm)

    18.07

  • Price/Book (mrq)

    9.37

  • Enterprise Value/Revenue

    17.23

  • Enterprise Value/EBITDA

    55.13

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    27.16%

  • Return on Assets (ttm)

    8.00%

  • Return on Equity (ttm)

    15.82%

  • Revenue (ttm)

    7.32B

  • Net Income Avi to Common (ttm)

    1.99B

  • Diluted EPS (ttm)

    5.53

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.8B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    529.38M

Research Analysis: ISRG

Analyst Price Targets

322.50 Low
418.24 Average
377.08 Current
475.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: ISRG

Fair Value

377.08 Current
 

Dividend Score

0 Low
ISRG
Sector Avg.
100 High
 

Hiring Score

0 Low
ISRG
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
ISRG
Sector Avg.
100 High
 

Research Reports: ISRG

  • The Argus Innovation Model Portfolio

    The United States economy is full of innovation. It has to be. Manufacturing industries that dominated the economy decades ago - textiles, televisions, even automobiles to a large degree - have moved overseas, where labor and materials costs are lower. Yet the U.S. economy, even during the pandemic and the current period of high inflation, has expanded to record levels. If U.S. corporations weren't innovating, creating new products (such as vaccines and AI) and services (such as Zoom calls) and moving into new markets, the domestic economy would not be growing, and capital would not be flooding into the country. The current high level of the U.S. dollar relative to currencies around the world attests to the confidence that global investors have in the durable and innovative U.S. economy.

     
  • Analyst Report: Intuitive Surgical, Inc.

    Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.

    Rating
    Price Target
     
  • Analyst Report: Intuitive Surgical, Inc.

    Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.

    Rating
    Price Target
     
  • Analyst Report: Intuitive Surgical, Inc.

    Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.

    Rating
    Price Target
     

People Also Watch